News
CDNA
30.06
-1.55%
-0.47
Capitulation in biotech is near, as well as a rally – Piper Sandler
Seeking Alpha · 9h ago
CareDx stock climbs 7% amid reports Natera not pursuing litigation
Seeking Alpha · 1d ago
Craig-Hallum Keeps Their Buy Rating on CareDx (CDNA)
TipRanks · 1d ago
Craig-Hallum says buy CareDx as Natera drops pursuit of infringement claims
TipRanks · 1d ago
Wednesday Sector Laggards: Sporting Goods & Activities, Diagnostics
NASDAQ · 2d ago
CareDx appoints Jing Huang as chief data and artificial intelligence officer
TipRanks · 2d ago
*CareDx Huang to Lead Key Data Science Initiatives >CDNA
Dow Jones · 2d ago
CAREDX APPOINTS JING HUANG CHIEF DATA AND AI OFFICER
Reuters · 2d ago
*CareDx Appoints Jing Huang Chief Data, AI Officer >CDNA
Dow Jones · 2d ago
CareDx Appoints Jing Huang Chief Data and AI Officer
Barchart · 2d ago
Buy Rating on CareDx: A Positive Outlook Amidst Legal Resolutions and Growth Potential
TipRanks · 2d ago
CareDx says DOJ has closed investigation, no wrongdoing found
Seeking Alpha · 3d ago
Interest Rate Regimes And ARKG: Underperformance Explained
Seeking Alpha · 3d ago
CareDx announces closure of DOJ investigation with no finding of wrongdoing
TipRanks · 3d ago
CareDx Says DOJ Has Concluded Its Investigation With No Finding Of Wrongdoing And Declined To Take Any Further Action; Plans To Defend Itself Should The Former Employee Choose To Proceed With Litigation
Benzinga · 3d ago
CAREDX INC - DOJ DECLINES TO INTERVENE IN QUI TAM ACTION AGAINST CAREDX
Reuters · 3d ago
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
Barchart · 3d ago
Weekly Report: what happened at CDNA last week (0930-1004)?
Weekly Report · 4d ago
Hedge funds pile into healthcare stocks amid dip, Goldman Sachs says
Seeking Alpha · 5d ago
CareDx Arranges Amicable Exit for Executive Alexander Johnson
TipRanks · 10/04 20:30
More
Webull provides a variety of real-time CDNA stock news. You can receive the latest news about Caredx through multiple platforms. This information may help you make smarter investment decisions.
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.